TRK-950 binds to human CAPRIN-1 with high affinity and can strongly induce tumor cell death through fragment crystallizable-mediated effector functions, including antibody-dependent cell-mediated cytotoxicity and antibody-dependent cell-mediated phagocytosis (ADCP). The gene discussed is CAPRIN1; the disease is neoplasm.